0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Skin Disease Treatment Market Size, Status and Forecast 2021-2027
Published Date: July 2021
|
Report Code: QYRE-Auto-29B5871
Home | Market Reports | Health | Health Conditions | Skin Conditions
Global Skin Disease Treatment Market Size Status and Forecast 2021 2027

Global Skin Disease Treatment Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-29B5871
Report
July 2021
106 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Skin Disease is a general term for diseases that occur in the skin and skin accessory organs. There are many types of it, and visceral diseases can also be manifested on the skin.
There are many causes of skin diseases. For example, skin diseases caused by infectious factors, such as leprosy, scabies, fungal diseases, and skin bacterial infections, are often infectious, which not only affects physical health but also causes panic and social discrimination. With the improvement of living standards and the advancement of science and technology, infectious diseases such as leprosy have been significantly controlled worldwide.
Market Analysis and Insights: Global Skin Disease Treatment Market
The global Skin Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Skin Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Skin Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Skin Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Skin Disease Treatment market.
Global Skin Disease Treatment Scope and Market Size
Skin Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Skin Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

Medicated Creams and Ointments
Antibiotics
Vitamins and Steroids
Antihistamines
Laser Therapy
Antifungals
Others

Segment by Application

Dermatology Clinics
Skincare Clinics
Hospitals
Aesthetic Centers
Others

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

APEIRON Biologics AG
HanAll BioPharma
GlaxoSmithKline plc.
Allergen, Plc.
Anacor Pharmaceuticals
Celgene
Basilea Pharmaceutica
Cipher Pharmaceuticals
Agenus
Astion Pharma A/S
Bristol-Myers Squibb
Almirall S.A.
Galderma
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Skin Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medicated Creams and Ointments
1.2.3 Antibiotics
1.2.4 Vitamins and Steroids
1.2.5 Antihistamines
1.2.6 Laser Therapy
1.2.7 Antifungals
1.2.8 Others
1.3 Market by Application
1.3.1 Global Skin Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Dermatology Clinics
1.3.3 Skincare Clinics
1.3.4 Hospitals
1.3.5 Aesthetic Centers
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Skin Disease Treatment Market Perspective (2016-2027)
2.2 Skin Disease Treatment Growth Trends by Regions
2.2.1 Skin Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Skin Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Skin Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Skin Disease Treatment Industry Dynamic
2.3.1 Skin Disease Treatment Market Trends
2.3.2 Skin Disease Treatment Market Drivers
2.3.3 Skin Disease Treatment Market Challenges
2.3.4 Skin Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Skin Disease Treatment Players by Revenue
3.1.1 Global Top Skin Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Skin Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Skin Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Skin Disease Treatment Revenue
3.4 Global Skin Disease Treatment Market Concentration Ratio
3.4.1 Global Skin Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Skin Disease Treatment Revenue in 2020
3.5 Skin Disease Treatment Key Players Head office and Area Served
3.6 Key Players Skin Disease Treatment Product Solution and Service
3.7 Date of Enter into Skin Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Skin Disease Treatment Breakdown Data by Type
4.1 Global Skin Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Skin Disease Treatment Forecasted Market Size by Type (2022-2027)
5 Skin Disease Treatment Breakdown Data by Application
5.1 Global Skin Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Skin Disease Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Skin Disease Treatment Market Size (2016-2027)
6.2 North America Skin Disease Treatment Market Size by Type
6.2.1 North America Skin Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Skin Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Skin Disease Treatment Market Size by Type (2016-2027)
6.3 North America Skin Disease Treatment Market Size by Application
6.3.1 North America Skin Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Skin Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Skin Disease Treatment Market Size by Application (2016-2027)
6.4 North America Skin Disease Treatment Market Size by Country
6.4.1 North America Skin Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Skin Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Skin Disease Treatment Market Size (2016-2027)
7.2 Europe Skin Disease Treatment Market Size by Type
7.2.1 Europe Skin Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Skin Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Skin Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Skin Disease Treatment Market Size by Application
7.3.1 Europe Skin Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Skin Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Skin Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Skin Disease Treatment Market Size by Country
7.4.1 Europe Skin Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Skin Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Skin Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Skin Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Skin Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Skin Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Skin Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Skin Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Skin Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Skin Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Skin Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Skin Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Skin Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Skin Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Skin Disease Treatment Market Size (2016-2027)
9.2 Latin America Skin Disease Treatment Market Size by Type
9.2.1 Latin America Skin Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Skin Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Skin Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Skin Disease Treatment Market Size by Application
9.3.1 Latin America Skin Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Skin Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Skin Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Skin Disease Treatment Market Size by Country
9.4.1 Latin America Skin Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Skin Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Skin Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Skin Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Skin Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Skin Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Skin Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Skin Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Skin Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Skin Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Skin Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Skin Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Skin Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Skin Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 APEIRON Biologics AG
11.1.1 APEIRON Biologics AG Company Details
11.1.2 APEIRON Biologics AG Business Overview
11.1.3 APEIRON Biologics AG Skin Disease Treatment Introduction
11.1.4 APEIRON Biologics AG Revenue in Skin Disease Treatment Business (2016-2021)
11.1.5 APEIRON Biologics AG Recent Development
11.2 HanAll BioPharma
11.2.1 HanAll BioPharma Company Details
11.2.2 HanAll BioPharma Business Overview
11.2.3 HanAll BioPharma Skin Disease Treatment Introduction
11.2.4 HanAll BioPharma Revenue in Skin Disease Treatment Business (2016-2021)
11.2.5 HanAll BioPharma Recent Development
11.3 GlaxoSmithKline plc.
11.3.1 GlaxoSmithKline plc. Company Details
11.3.2 GlaxoSmithKline plc. Business Overview
11.3.3 GlaxoSmithKline plc. Skin Disease Treatment Introduction
11.3.4 GlaxoSmithKline plc. Revenue in Skin Disease Treatment Business (2016-2021)
11.3.5 GlaxoSmithKline plc. Recent Development
11.4 Allergen, Plc.
11.4.1 Allergen, Plc. Company Details
11.4.2 Allergen, Plc. Business Overview
11.4.3 Allergen, Plc. Skin Disease Treatment Introduction
11.4.4 Allergen, Plc. Revenue in Skin Disease Treatment Business (2016-2021)
11.4.5 Allergen, Plc. Recent Development
11.5 Anacor Pharmaceuticals
11.5.1 Anacor Pharmaceuticals Company Details
11.5.2 Anacor Pharmaceuticals Business Overview
11.5.3 Anacor Pharmaceuticals Skin Disease Treatment Introduction
11.5.4 Anacor Pharmaceuticals Revenue in Skin Disease Treatment Business (2016-2021)
11.5.5 Anacor Pharmaceuticals Recent Development
11.6 Celgene
11.6.1 Celgene Company Details
11.6.2 Celgene Business Overview
11.6.3 Celgene Skin Disease Treatment Introduction
11.6.4 Celgene Revenue in Skin Disease Treatment Business (2016-2021)
11.6.5 Celgene Recent Development
11.7 Basilea Pharmaceutica
11.7.1 Basilea Pharmaceutica Company Details
11.7.2 Basilea Pharmaceutica Business Overview
11.7.3 Basilea Pharmaceutica Skin Disease Treatment Introduction
11.7.4 Basilea Pharmaceutica Revenue in Skin Disease Treatment Business (2016-2021)
11.7.5 Basilea Pharmaceutica Recent Development
11.8 Cipher Pharmaceuticals
11.8.1 Cipher Pharmaceuticals Company Details
11.8.2 Cipher Pharmaceuticals Business Overview
11.8.3 Cipher Pharmaceuticals Skin Disease Treatment Introduction
11.8.4 Cipher Pharmaceuticals Revenue in Skin Disease Treatment Business (2016-2021)
11.8.5 Cipher Pharmaceuticals Recent Development
11.9 Agenus
11.9.1 Agenus Company Details
11.9.2 Agenus Business Overview
11.9.3 Agenus Skin Disease Treatment Introduction
11.9.4 Agenus Revenue in Skin Disease Treatment Business (2016-2021)
11.9.5 Agenus Recent Development
11.10 Astion Pharma A/S
11.10.1 Astion Pharma A/S Company Details
11.10.2 Astion Pharma A/S Business Overview
11.10.3 Astion Pharma A/S Skin Disease Treatment Introduction
11.10.4 Astion Pharma A/S Revenue in Skin Disease Treatment Business (2016-2021)
11.10.5 Astion Pharma A/S Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Skin Disease Treatment Introduction
11.11.4 Bristol-Myers Squibb Revenue in Skin Disease Treatment Business (2016-2021)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 Almirall S.A.
11.12.1 Almirall S.A. Company Details
11.12.2 Almirall S.A. Business Overview
11.12.3 Almirall S.A. Skin Disease Treatment Introduction
11.12.4 Almirall S.A. Revenue in Skin Disease Treatment Business (2016-2021)
11.12.5 Almirall S.A. Recent Development
11.13 Galderma
11.13.1 Galderma Company Details
11.13.2 Galderma Business Overview
11.13.3 Galderma Skin Disease Treatment Introduction
11.13.4 Galderma Revenue in Skin Disease Treatment Business (2016-2021)
11.13.5 Galderma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Skin Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Medicated Creams and Ointments
    Table 3. Key Players of Antibiotics
    Table 4. Key Players of Vitamins and Steroids
    Table 5. Key Players of Antihistamines
    Table 6. Key Players of Laser Therapy
    Table 7. Key Players of Antifungals
    Table 8. Key Players of Others
    Table 9. Global Skin Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Skin Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 11. Global Skin Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 12. Global Skin Disease Treatment Market Share by Regions (2016-2021)
    Table 13. Global Skin Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 14. Global Skin Disease Treatment Market Share by Regions (2022-2027)
    Table 15. Skin Disease Treatment Market Trends
    Table 16. Skin Disease Treatment Market Drivers
    Table 17. Skin Disease Treatment Market Challenges
    Table 18. Skin Disease Treatment Market Restraints
    Table 19. Global Skin Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 20. Global Skin Disease Treatment Market Share by Players (2016-2021)
    Table 21. Global Top Skin Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Disease Treatment as of 2020)
    Table 22. Ranking of Global Top Skin Disease Treatment Companies by Revenue (US$ Million) in 2020
    Table 23. Global 5 Largest Players Market Share by Skin Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Skin Disease Treatment Product Solution and Service
    Table 26. Date of Enter into Skin Disease Treatment Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Skin Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 29. Global Skin Disease Treatment Revenue Market Share by Type (2016-2021)
    Table 30. Global Skin Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 31. Global Skin Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 32. Global Skin Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 33. Global Skin Disease Treatment Revenue Market Share by Application (2016-2021)
    Table 34. Global Skin Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 35. Global Skin Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 36. North America Skin Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 37. North America Skin Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 38. North America Skin Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 39. North America Skin Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 40. North America Skin Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 41. North America Skin Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 42. Europe Skin Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 43. Europe Skin Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 44. Europe Skin Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 45. Europe Skin Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 46. Europe Skin Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 47. Europe Skin Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Skin Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Skin Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Skin Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 51. Asia-Pacific Skin Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 52. Asia-Pacific Skin Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
    Table 53. Asia-Pacific Skin Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
    Table 54. Latin America Skin Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 55. Latin America Skin Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 56. Latin America Skin Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 57. Latin America Skin Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 58. Latin America Skin Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 59. Latin America Skin Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Skin Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Skin Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Skin Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 63. Middle East & Africa Skin Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 64. Middle East & Africa Skin Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 65. Middle East & Africa Skin Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 66. APEIRON Biologics AG Company Details
    Table 67. APEIRON Biologics AG Business Overview
    Table 68. APEIRON Biologics AG Skin Disease Treatment Product
    Table 69. APEIRON Biologics AG Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
    Table 70. APEIRON Biologics AG Recent Development
    Table 71. HanAll BioPharma Company Details
    Table 72. HanAll BioPharma Business Overview
    Table 73. HanAll BioPharma Skin Disease Treatment Product
    Table 74. HanAll BioPharma Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
    Table 75. HanAll BioPharma Recent Development
    Table 76. GlaxoSmithKline plc. Company Details
    Table 77. GlaxoSmithKline plc. Business Overview
    Table 78. GlaxoSmithKline plc. Skin Disease Treatment Product
    Table 79. GlaxoSmithKline plc. Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
    Table 80. GlaxoSmithKline plc. Recent Development
    Table 81. Allergen, Plc. Company Details
    Table 82. Allergen, Plc. Business Overview
    Table 83. Allergen, Plc. Skin Disease Treatment Product
    Table 84. Allergen, Plc. Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
    Table 85. Allergen, Plc. Recent Development
    Table 86. Anacor Pharmaceuticals Company Details
    Table 87. Anacor Pharmaceuticals Business Overview
    Table 88. Anacor Pharmaceuticals Skin Disease Treatment Product
    Table 89. Anacor Pharmaceuticals Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
    Table 90. Anacor Pharmaceuticals Recent Development
    Table 91. Celgene Company Details
    Table 92. Celgene Business Overview
    Table 93. Celgene Skin Disease Treatment Product
    Table 94. Celgene Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
    Table 95. Celgene Recent Development
    Table 96. Basilea Pharmaceutica Company Details
    Table 97. Basilea Pharmaceutica Business Overview
    Table 98. Basilea Pharmaceutica Skin Disease Treatment Product
    Table 99. Basilea Pharmaceutica Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
    Table 100. Basilea Pharmaceutica Recent Development
    Table 101. Cipher Pharmaceuticals Company Details
    Table 102. Cipher Pharmaceuticals Business Overview
    Table 103. Cipher Pharmaceuticals Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
    Table 104. Cipher Pharmaceuticals Recent Development
    Table 105. Agenus Company Details
    Table 106. Agenus Business Overview
    Table 107. Agenus Skin Disease Treatment Product
    Table 108. Agenus Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
    Table 109. Agenus Recent Development
    Table 110. Astion Pharma A/S Company Details
    Table 111. Astion Pharma A/S Business Overview
    Table 112. Astion Pharma A/S Skin Disease Treatment Product
    Table 113. Astion Pharma A/S Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
    Table 114. Astion Pharma A/S Recent Development
    Table 115. Bristol-Myers Squibb Company Details
    Table 116. Bristol-Myers Squibb Business Overview
    Table 117. Bristol-Myers Squibb Skin Disease Treatment Product
    Table 118. Bristol-Myers Squibb Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
    Table 119. Bristol-Myers Squibb Recent Development
    Table 120. Almirall S.A. Company Details
    Table 121. Almirall S.A. Business Overview
    Table 122. Almirall S.A. Skin Disease Treatment Product
    Table 123. Almirall S.A. Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
    Table 124. Almirall S.A. Recent Development
    Table 125. Galderma Company Details
    Table 126. Galderma Business Overview
    Table 127. Galderma Skin Disease Treatment Product
    Table 128. Galderma Revenue in Skin Disease Treatment Business (2016-2021) & (US$ Million)
    Table 129. Galderma Recent Development
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Skin Disease Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Medicated Creams and Ointments Features
    Figure 3. Antibiotics Features
    Figure 4. Vitamins and Steroids Features
    Figure 5. Antihistamines Features
    Figure 6. Laser Therapy Features
    Figure 7. Antifungals Features
    Figure 8. Others Features
    Figure 9. Global Skin Disease Treatment Market Share by Application: 2020 VS 2027
    Figure 10. Dermatology Clinics Case Studies
    Figure 11. Skincare Clinics Case Studies
    Figure 12. Hospitals Case Studies
    Figure 13. Aesthetic Centers Case Studies
    Figure 14. Others Case Studies
    Figure 15. Skin Disease Treatment Report Years Considered
    Figure 16. Global Skin Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 17. Global Skin Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 18. Global Skin Disease Treatment Market Share by Regions: 2020 VS 2027
    Figure 19. Global Skin Disease Treatment Market Share by Regions (2022-2027)
    Figure 20. Global Skin Disease Treatment Market Share by Players in 2020
    Figure 21. Global Top Skin Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Skin Disease Treatment as of 2020
    Figure 22. The Top 10 and 5 Players Market Share by Skin Disease Treatment Revenue in 2020
    Figure 23. Global Skin Disease Treatment Revenue Market Share by Type (2016-2021)
    Figure 24. Global Skin Disease Treatment Revenue Market Share by Type (2022-2027)
    Figure 25. North America Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. North America Skin Disease Treatment Market Share by Type (2016-2027)
    Figure 27. North America Skin Disease Treatment Market Share by Application (2016-2027)
    Figure 28. North America Skin Disease Treatment Market Share by Country (2016-2027)
    Figure 29. United States Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Canada Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Europe Skin Disease Treatment Market Share by Type (2016-2027)
    Figure 33. Europe Skin Disease Treatment Market Share by Application (2016-2027)
    Figure 34. Europe Skin Disease Treatment Market Share by Country (2016-2027)
    Figure 35. Germany Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. France Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. U.K. Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Italy Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Russia Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Nordic Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Asia-Pacific Skin Disease Treatment Market Share by Type (2016-2027)
    Figure 43. Asia-Pacific Skin Disease Treatment Market Share by Application (2016-2027)
    Figure 44. Asia-Pacific Skin Disease Treatment Market Share by Region (2016-2027)
    Figure 45. China Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Japan Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. South Korea Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Southeast Asia Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. India Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Australia Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Latin America Skin Disease Treatment Market Share by Type (2016-2027)
    Figure 53. Latin America Skin Disease Treatment Market Share by Application (2016-2027)
    Figure 54. Latin America Skin Disease Treatment Market Share by Country (2016-2027)
    Figure 55. Mexico Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Brazil Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Middle East & Africa Skin Disease Treatment Market Share by Type (2016-2027)
    Figure 59. Middle East & Africa Skin Disease Treatment Market Share by Application (2016-2027)
    Figure 60. Middle East & Africa Skin Disease Treatment Market Share by Country (2016-2027)
    Figure 61. Turkey Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. Saudi Arabia Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. UAE Skin Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 64. APEIRON Biologics AG Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
    Figure 65. HanAll BioPharma Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
    Figure 66. GlaxoSmithKline plc. Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
    Figure 67. Allergen, Plc. Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
    Figure 68. Anacor Pharmaceuticals Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
    Figure 69. Celgene Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
    Figure 70. Basilea Pharmaceutica Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
    Figure 71. Cipher Pharmaceuticals Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
    Figure 72. Agenus Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
    Figure 73. Astion Pharma A/S Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
    Figure 74. Bristol-Myers Squibb Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
    Figure 75. Almirall S.A. Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
    Figure 76. Galderma Revenue Growth Rate in Skin Disease Treatment Business (2016-2021)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Seventh Sense AI

RELATED REPORTS

Global and China Atopic Eczema Treatment Market Size Status and Forecast 2021 2027
Global and China Atopic Eczema Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-35G6515
Sun Sep 05 00:00:00 UTC 2021

Add to Cart

Global Scar Treatment Product Sales Market Report 2021
Global Scar Treatment Product Sales Market Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-18X6311
Fri Aug 13 00:00:00 UTC 2021

Add to Cart

China Acne Medicine Market Report Forecast 2021 2027
China Acne Medicine Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-18Z1804
Wed Aug 11 00:00:00 UTC 2021

Add to Cart

China Actinic Keratosis Treatment Market Report Forecast 2021 2027
China Actinic Keratosis Treatment Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-20A2320
Wed Aug 11 00:00:00 UTC 2021

Add to Cart